ATA260486A - Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes - Google Patents

Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes

Info

Publication number
ATA260486A
ATA260486A AT0260486A AT260486A ATA260486A AT A260486 A ATA260486 A AT A260486A AT 0260486 A AT0260486 A AT 0260486A AT 260486 A AT260486 A AT 260486A AT A260486 A ATA260486 A AT A260486A
Authority
AT
Austria
Prior art keywords
benzoxadiazol
dihydro
dimethyl
pharmaceutical compositions
active substance
Prior art date
Application number
AT0260486A
Other languages
English (en)
Other versions
AT402257B (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA260486A publication Critical patent/ATA260486A/de
Application granted granted Critical
Publication of AT402257B publication Critical patent/AT402257B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT0260486A 1985-10-01 1986-09-30 Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes AT402257B (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ATA260486A true ATA260486A (de) 1996-08-15
AT402257B AT402257B (de) 1997-03-25

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0260486A AT402257B (de) 1985-10-01 1986-09-30 Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes

Country Status (20)

Country Link
KR (1) KR920008817B1 (de)
AT (1) AT402257B (de)
BE (1) BE905516A (de)
CA (1) CA1298784C (de)
CH (1) CH669524A5 (de)
DE (1) DE3632201C2 (de)
DK (1) DK170016B1 (de)
ES (1) ES2002508A6 (de)
FR (1) FR2589732B1 (de)
GR (1) GR862457B (de)
HK (1) HK392A (de)
HU (1) HU197201B (de)
IE (1) IE59589B1 (de)
IL (1) IL80182A (de)
LU (1) LU86615A1 (de)
NL (1) NL194822C (de)
NZ (1) NZ217732A (de)
PT (1) PT83456B (de)
SE (1) SE503222C2 (de)
SG (1) SG103391G (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
WO2003065970A2 (en) * 2001-02-20 2003-08-14 Royal College Of Surgeons Ie Treatment of fibromyalgia and related fatigue syndromes using pindolol
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DD145004A3 (de) * 1978-09-25 1980-11-19 Reinhard Huettenrauch Verfahren zur herstellung fester a zneiformen
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
WO1985004100A1 (en) * 1984-03-21 1985-09-26 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤

Also Published As

Publication number Publication date
DK464686A (da) 1987-04-02
CH669524A5 (de) 1989-03-31
NL194822B (nl) 2002-12-02
IL80182A0 (en) 1986-12-31
HK392A (en) 1992-01-10
IL80182A (en) 1991-01-31
ES2002508A6 (es) 1988-08-16
DE3632201A1 (de) 1987-04-02
CA1298784C (en) 1992-04-14
SE503222C2 (sv) 1996-04-22
PT83456B (pt) 1989-05-12
KR920008817B1 (ko) 1992-10-09
NL8602370A (nl) 1987-05-04
NL194822C (nl) 2003-04-03
DK170016B1 (da) 1995-05-01
PT83456A (en) 1986-10-01
HUT44701A (en) 1988-04-28
DK464686D0 (da) 1986-09-29
GR862457B (en) 1987-01-29
LU86615A1 (fr) 1987-04-02
SG103391G (en) 1992-01-17
SE8604112L (sv) 1987-04-02
FR2589732B1 (fr) 1989-07-13
NZ217732A (en) 1990-07-26
IE862565L (en) 1987-04-01
AT402257B (de) 1997-03-25
KR870003777A (ko) 1987-05-04
SE8604112D0 (sv) 1986-09-29
IE59589B1 (en) 1994-03-09
HU197201B (en) 1989-03-28
DE3632201C2 (de) 1997-05-07
FR2589732A1 (fr) 1987-05-15
BE905516A (fr) 1987-03-30

Similar Documents

Publication Publication Date Title
JPS55301A (en) 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
ATA245485A (de) Verfahren zur herstellung von neuen dihydropyridincarbonsaeure-derivaten
FI881978L (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
AT382779B (de) Verfahren zur herstellung von festen pharmazeutischen dispersionszusammensetzungen mit rascher wirkstofffreisetzung
PH27356A (en) Annelated tetrahydropyridine acetic acid derivatives pharmaceutical composition containing said compound and method of use thereof
ATA82386A (de) Verfahren zur herstellung von neuen 7beta-(2-(2amino-4-thiazolyl)-alkenoylamino)-3-cephem-4- carbonsaeureestern
DE59310153D1 (de) Verfahren zur Herstellung von 4-Hydroxy-2.2.6.6-tetramethylpiperidin
DE3673708D1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
ATA327685A (de) Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates
AT352728B (de) Verfahren zur herstellung von neuen tetrahydro- pyridin und piperidinderivaten und ihren saeureadditionssalzen
DE69114743D1 (de) Verfahren zur Herstellung von Fluormethyl-substituierten Dihydropyridin-carbodithioaten.
AT385990B (de) Verfahren zur herstellung von neuen racemischen und optisch aktiven eburnan-oxim-derivaten sowie von saeureadditions-salzen derselben
NZ217732A (en) Controlled release formulation for oral administration which includes either pindolol or a 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester
EE9500055A (et) 1,4-dihüdropüridiin-3,5-dikarboksüülhappeestrite kasutamine ravimitena, ravimid ja nende valmistamismeetod
DE3861897D1 (de) Verfahren zur herstellung von 4-hydroxy-2,2,6,6-tetramethyl-piperidin.
ATA143787A (de) Verfahren zur herstellung von neuen derivaten der 4-phenyl 4-oxo 2-butensaeure
ATA326986A (de) Verfahren zur herstellung von neuen optisch aktiven 2-chlor-12-/3-dimethylamino-2-methylpropyl/-12h-dibenzo/d,g//1,3,6/dioxazocinen und saeureadditionssalzen derselben
DK169185D0 (da) Dihydropyridin-3,5-dicarboxylsyreesterderivater, fremgangsmaade tilfremstilling heraf og farmaceutiske praeparater indeholdende disse
DK468385A (da) Fremgangsmaade til fremstilling af den optiske d-isomer af diastereomeren aeaae af 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-(1-benzylpyrrolidin-3-yl)-ester-5-methylester
ATE118205T1 (de) Verfahren zur herstellung der optischen isomeren von 1,4-dihydro-5-isopropoxy-2-methyl-4-(2- trifluormethylphenyl)-1,6-naphthyridin-3- carbonsäure-ethyl-ester und 1,4-dihydro-5-
DE68922605D1 (de) Verfahren zur Herstellung von (-)2-(2-(2-Aminoethoxy)ethoxy)methyl)-4-(2,3-dichlorphenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridin, und Zwischenprodukt zu dessen Herstellung.
ATA902489A (de) Verfahren zur herstellung von chinolincarbonsäurederivaten
AU626404B2 (en) A controlled release formulation of 4-(2,1,3-benzoxadizaol-4 -yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester
AT380876B (de) Verfahren zur herstellung von 4-(2'-nitrophenyl)2,6-dimethyl-3,5-dimethoxycarbonyl-1,4 -dihydropyridin
PT80521B (en) Process for the preparation of esters of the 1,4-dihydro-2,6-dimethyl-3-(alcoxicarbonyl or alcoxialcoxicarbonyl)-4-(substituted phenyl) pyridin-5-carboxylic acid of stereochemical isomers and pharmaceutically acceptable salts thereof

Legal Events

Date Code Title Description
ELA Expired due to lapse of time